Societal Benefits of Reducing Lead: Estimating Value of Fewer Premature CVD-Related Deaths
Cardiovascular disease is the leading cause of death in the U.S., so even a small reduction in the risk can yield significant benefits for society.
Cardiovascular disease is the leading cause of death in the U.S., so even a small reduction in the risk can yield significant benefits for society.
Codex sets weak international standards so at least 95% of ingredients will pass.
Spotting the loss of an IQ point in a child is not possible. However, powerful statistical tools enable us to “see” the loss in terms of public health and societal impacts.
Inaction for the right reasons might send the wrong message.
EPA’s decade-long failure to ban lead wheel weights leaves workers and families bearing the burden of exposure.
Lead exposure is a cardiovascular risk factor on par with high cholesterol, smoking, and high blood pressure. That message needs more attention.
There is a need for better point-of-care blood lead testing devices. We encourage all innovators to move forward with their devices.
EPA improved its Lead and Copper Rule and revamped its interior dust lead standards, turning years of talk about “no safe level of lead exposure” into policy and action.
FDA needs to get the lead and cadmium action levels out by December as promised and then do more to protect millions of infants and young children.
